| Lactose (India) Ltd |         145                  Cr. |         115 |  247/84.3 | 33.0 |         46.7 | 0.00                  % | 12.9                  % | 9.69                  % |         10.0 | 
| MPS Pharmaa Ltd |         3.63                  Cr. |         1.90 |  4.33/1.90 |  |         0.57 | 0.00                  % | 9.79                  % | 59.0                  % |         10.0 | 
| Gujarat Themis Biosyn Ltd |         5,079                  Cr. |         464 |  479/192 | 114 |         22.8 | 0.14                  % | 27.3                  % | 21.7                  % |         1.00 | 
| Gujarat Terce Laboratories Ltd |         34.5                  Cr. |         46.5 |  94.9/37.2 |  |         8.73 | 0.00                  % | 41.4                  % | 14.6                  % |         10.0 | 
| Gujarat Inject (Kerala) Ltd |         35.1                  Cr. |         24.0 |  29.1/17.0 | 36.6 |         6.83 | 0.00                  % | 13.5                  % | 11.0                  % |         10.0 | 
| Godavari Drugs Ltd |         65.3                  Cr. |         86.7 |  134/78.9 | 17.2 |         57.6 | 0.00                  % | 10.1                  % | 10.6                  % |         10.0 | 
| Glenmark Life Sciences Ltd |         53,597                  Cr. |         1,898 |  2,286/1,275 | 40.2 |         314 | 0.13                  % | 19.4                  % | 15.8                  % |         1.00 | 
| Gennex Laboratories Ltd |         352                  Cr. |         15.5 |  22.5/10.8 | 21.4 |         8.21 | 0.00                  % | 13.0                  % | 10.2                  % |         1.00 | 
| Ganga Pharmaceuticals Ltd |         7.06                  Cr. |         14.6 |  19.2/9.25 | 88.2 |         14.7 | 0.00                  % | 3.18                  % | 1.13                  % |         10.0 | 
| Fredun Pharmaceuticals Ltd |         734                  Cr. |         1,554 |  1,785/635 | 31.3 |         299 | 0.05                  % | 18.9                  % | 15.8                  % |         10.0 | 
| Fervent Synergies Ltd |         108                  Cr. |         21.6 |  32.0/15.0 | 33.0 |         11.1 | 0.00                  % | 7.47                  % | 7.47                  % |         10.0 | 
| Fermenta Biotech Ltd |         828                  Cr. |         281 |  449/219 | 7.92 |         123 | 0.89                  % | 23.0                  % | 24.9                  % |         5.00 | 
| Fabino Enterprises Ltd |         4.83                  Cr. |         23.0 |  39.0/22.8 | 37.2 |         20.4 | 0.00                  % | 7.16                  % | 3.08                  % |         10.0 | 
| Evoq Remedies Ltd |         11.6                  Cr. |         4.67 |  9.28/2.11 | 6.61 |         17.9 | 0.00                  % | 0.35                  % | 0.26                  % |         10.0 | 
| Everest Organics Ltd |         388                  Cr. |         400 |  477/112 | 62.6 |         72.0 | 0.00                  % | 1.76                  % | 2.23                  % |         10.0 | 
| Entero Healthcare Solutions Ltd |         4,806                  Cr. |         1,104 |  1,584/1,045 | 46.9 |         396 | 0.00                  % | 8.71                  % | 5.63                  % |         10.0 | 
| Murae Organisor Ltd |         55.2                  Cr. |         0.27 |  1.24/0.26 | 3.63 |         1.02 | 0.00                  % | 4.20                  % | 5.69                  % |         1.00 | 
| Dipna Pharmachem Ltd |         46.9                  Cr. |         19.5 |  26.3/6.40 | 48.4 |         16.0 | 0.00                  % | 6.64                  % | 2.55                  % |         10.0 | 
| Decipher Labs Ltd |         9.82                  Cr. |         9.73 |  17.2/9.01 |  |         22.6 | 0.00                  % | 4.67                  % | 1.16                  % |         10.0 | 
| Coral Laboratories Ltd |         177                  Cr. |         495 |  896/443 | 9.57 |         563 | 0.30                  % | 17.4                  % | 13.1                  % |         10.0 | 
| Concord Drugs Ltd |         67.0                  Cr. |         67.0 |  71.5/26.1 | 172 |         34.1 | 0.00                  % | 4.73                  % | 0.88                  % |         10.0 | 
| Concord Biotech Ltd |         15,388                  Cr. |         1,470 |  2,452/1,345 | 43.1 |         173 | 0.73                  % | 28.4                  % | 21.4                  % |         1.00 | 
| Colinz Laboratories Ltd |         19.4                  Cr. |         42.4 |  88.7/37.6 | 42.2 |         21.6 | 0.00                  % | 6.72                  % | 5.43                  % |         10.0 | 
| Cian Healthcare Ltd |         18.1                  Cr. |         7.23 |  7.23/2.97 |  |         15.8 | 0.00                  % | 5.22                  % | 0.43                  % |         10.0 | 
| Chemo Pharma Laboratories Ltd |         18.6                  Cr. |         124 |  154/63.0 |  |         87.6 | 0.00                  % | 5.17                  % | 3.47                  % |         10.0 | 
| Checkpoint Trends Ltd |         38.1                  Cr. |         69.6 |  69.6/9.41 | 423 |         1.02 | 0.00                  % | 16.5                  % | 9.17                  % |         10.0 | 
| Chandra Bhagat Pharma Ltd |         31.0                  Cr. |         41.1 |  80.0/0.00 | 43.7 |         39.7 | 0.00                  % | 6.00                  % | 2.41                  % |         10.0 | 
| Brawn Biotech Ltd |         6.33                  Cr. |         21.1 |  26.0/15.5 |  |         11.2 | 0.00                  % | 42.5                  % | 41.3                  % |         10.0 | 
| Blue Jet Healthcare Ltd |         11,694                  Cr. |         674 |  1,028/468 | 32.6 |         65.3 | 0.18                  % | 39.8                  % | 30.2                  % |         2.00 | 
| Bharat Immunological & Biological Corporation Ltd |         88.2                  Cr. |         20.4 |  35.9/19.0 |  |         18.2 | 0.00                  % | 9.27                  % | 17.7                  % |         10.0 | 
| Beryl Drugs Ltd |         11.7                  Cr. |         23.2 |  43.7/17.4 | 51.1 |         18.7 | 0.00                  % | 10.2                  % | 6.30                  % |         10.0 | 
| Mankind Pharma Ltd |         99,110                  Cr. |         2,400 |  3,055/2,115 | 54.8 |         355 | 0.04                  % | 15.0                  % | 13.9                  % |         1.00 | 
| BDH Industries Ltd |         244                  Cr. |         424 |  524/241 | 25.6 |         119 | 1.06                  % | 17.8                  % | 14.2                  % |         10.0 | 
| Bacil Pharma Ltd |         47.1                  Cr. |         32.8 |  62.6/31.6 | 42.4 |         17.7 | 0.00                  % | 0.97                  % | 0.98                  % |         10.0 | 
| Aurobindo Pharma Ltd |         67,902                  Cr. |         1,159 |  1,417/994 | 20.0 |         557 | 0.35                  % | 14.2                  % | 11.1                  % |         1.00 | 
| Auro Laboratories Ltd |         123                  Cr. |         197 |  303/170 | 178 |         69.0 | 0.00                  % | 3.85                  % | 4.33                  % |         10.0 | 
| Anuh Pharma Ltd |         893                  Cr. |         89.2 |  123/74.0 | 19.4 |         32.5 | 1.68                  % | 17.2                  % | 13.4                  % |         5.00 | 
| ANG Lifesciences India Ltd |         40.2                  Cr. |         30.8 |  50.0/21.0 |  |         51.2 | 0.00                  % | 3.54                  % | 13.8                  % |         10.0 | 
| Acutaas Chemicals Ltd |         14,855                  Cr. |         1,810 |  1,868/919 | 66.3 |         160 | 0.08                  % | 19.9                  % | 16.0                  % |         5.00 | 
| Amerise Biosciences Ltd |         4.23                  Cr. |         0.64 |  1.45/0.55 | 84.5 |         0.81 | 0.00                  % | 0.19                  % | 0.19                  % |         1.00 | 
| Ambalal Sarabhai Enterprises Ltd |         247                  Cr. |         32.3 |  68.0/30.0 | 13.2 |         18.3 | 0.00                  % | 9.12                  % | 6.25                  % |         10.0 | 
| Adline Chem Lab Ltd |         8.71                  Cr. |         14.9 |  25.5/9.40 |  |         2.55 | 0.00                  % | % | % |         10.0 | 
| Achyut Healthcare Ltd |         130                  Cr. |         5.53 |  6.57/2.82 | 303 |         1.33 | 0.00                  % | 2.26                  % | 1.77                  % |         1.00 | 
| Abbott India Ltd |         61,682                  Cr. |         29,035 |  37,000/25,260 | 42.5 |         1,992 | 1.64                  % | 46.2                  % | 35.7                  % |         10.0 | 
| Aarti Pharmalabs Ltd |         7,787                  Cr. |         858 |  972/550 | 29.2 |         220 | 0.58                  % | 17.4                  % | 14.5                  % |         5.00 | 
| Aarey Drugs & Pharmaceuticals Ltd |         274                  Cr. |         96.2 |  96.9/31.3 | 66.0 |         48.8 | 0.00                  % | 6.38                  % | 2.96                  % |         10.0 | 
| Zota Health Care Ltd |         4,778                  Cr. |         1,575 |  1,628/535 |  |         104 | 0.06                  % | 17.0                  % | 36.0                  % |         10.0 | 
| Wockhardt Ltd |         22,977                  Cr. |         1,414 |  1,870/1,110 | 419 |         281 | 0.00                  % | 3.75                  % | 1.22                  % |         5.00 | 
| Wanbury Ltd |         920                  Cr. |         264 |  330/154 | 21.4 |         18.1 | 0.00                  % | 36.7                  % | 76.5                  % |         10.0 | 
| Vivimed Labs Ltd |         41.0                  Cr. |         4.95 |  / |  |         4.24 | 0.00                  % | 8.10                  % | % |         2.00 | 
| Venus Remedies Ltd |         593                  Cr. |         444 |  568/270 | 12.7 |         420 | 0.00                  % | 11.1                  % | 7.16                  % |         10.0 | 
| Unichem Laboratories Ltd |         3,354                  Cr. |         475 |  950/455 | 26.8 |         348 | 0.00                  % | 6.24                  % | 5.59                  % |         2.00 | 
| TTK Healthcare Ltd |         1,665                  Cr. |         1,175 |  1,595/991 | 23.6 |         768 | 0.85                  % | 9.26                  % | 6.89                  % |         10.0 | 
| Torrent Pharmaceuticals Ltd |         1,22,827                  Cr. |         3,628 |  3,790/2,886 | 60.8 |         224 | 0.88                  % | 27.0                  % | 26.5                  % |         5.00 | 
| Themis Medicare Ltd |         1,149                  Cr. |         125 |  317/98.0 |  |         43.7 | 0.40                  % | 10.4                  % | 7.65                  % |         1.00 | 
| Syncom Formulations (India) Ltd |         1,558                  Cr. |         16.6 |  24.0/14.1 | 27.4 |         3.62 | 0.00                  % | 18.6                  % | 15.5                  % |         1.00 | 
| Cohance Lifesciences Ltd |         28,427                  Cr. |         743 |  1,360/730 | 80.8 |         66.6 | 0.00                  % | 14.9                  % | 12.7                  % |         1.00 | 
| Suven Life Sciences Ltd |         4,659                  Cr. |         205 |  303/102 |  |         5.04 | 0.00                  % | 87.0                  % | 87.2                  % |         1.00 | 
| Sun Pharmaceuticals Industries Ltd |         4,09,628                  Cr. |         1,706 |  1,910/1,547 | 35.7 |         301 | 0.94                  % | 20.2                  % | 16.9                  % |         1.00 | 
| Solara Active Pharma Sciences Ltd |         2,813                  Cr. |         632 |  886/441 | 115 |         304 | 0.00                  % | 6.01                  % | 0.05                  % |         10.0 | 
| SMS Pharmaceuticals Ltd |         2,633                  Cr. |         282 |  319/175 | 37.5 |         75.9 | 0.14                  % | 12.2                  % | 11.0                  % |         1.00 | 
| SMS Lifesciences India Ltd |         357                  Cr. |         1,197 |  1,680/956 | 20.6 |         650 | 0.13                  % | 11.8                  % | 10.8                  % |         10.0 | 
| Shilpa Medicare Ltd |         7,153                  Cr. |         367 |  502/265 | 55.6 |         121 | 0.14                  % | 7.82                  % | 4.21                  % |         1.00 | 
| Sequent Scientific Ltd |         5,472                  Cr. |         218 |  232/111 | 181 |         28.1 | 0.00                  % | 8.47                  % | 3.21                  % |         2.00 | 
| Sanofi India Ltd |         11,016                  Cr. |         4,783 |  6,823/4,146 | 29.8 |         340 | 2.45                  % | 49.2                  % | 47.2                  % |         10.0 | 
| RPG Life Sciences Ltd |         4,032                  Cr. |         2,441 |  2,776/1,772 | 36.2 |         335 | 0.82                  % | 32.8                  % | 25.5                  % |         8.00 | 
| Procter & Gamble Health Ltd |         10,089                  Cr. |         6,086 |  6,739/4,904 | 33.6 |         323 | 2.05                  % | 47.8                  % | 36.4                  % |         10.0 | 
| Pharmaids Pharmaceuticals Ltd |         176                  Cr. |         49.8 |  87.5/42.0 |  |         16.8 | 0.00                  % | 17.4                  % | 16.3                  % |         10.0 | 
| Pfizer Ltd |         23,711                  Cr. |         5,182 |  5,993/3,701 | 35.1 |         922 | 0.68                  % | 21.6                  % | 16.4                  % |         10.0 | 
| Par Drugs & Chemicals Ltd |         125                  Cr. |         102 |  348/81.0 | 8.84 |         80.4 | 0.00                  % | 18.4                  % | 13.6                  % |         10.0 | 
| Panacea Biotec Ltd |         2,646                  Cr. |         432 |  582/281 |  |         136 | 0.00                  % | 4.57                  % | 4.92                  % |         1.00 | 
| Ortin Laboratories Ltd |         16.4                  Cr. |         20.1 | 26.4/16.2 |  |         3.47 | 0.00                  % | 60.2                  % | 118                  % |         10.0 | 
| Orchid Pharma Ltd |         3,909                  Cr. |         770 |  1,998/604 | 45.9 |         250 | 0.00                  % | 8.07                  % | 8.21                  % |         10.0 | 
| Neuland Laboratories Ltd |         21,957                  Cr. |         17,159 |  18,100/10,060 | 167 |         1,188 | 0.07                  % | 18.7                  % | 14.8                  % |         10.0 | 
| Nectar Lifescience Ltd |         328                  Cr. |         14.8 |  44.9/13.0 |  |         42.6 | 0.00                  % | 5.36                  % | 11.2                  % |         1.00 | 
| Natco Pharma Ltd |         14,888                  Cr. |         832 |  1,505/660 | 8.77 |         425 | 0.72                  % | 32.8                  % | 28.0                  % |         2.00 | 
| Morepen Laboratories Ltd |         2,637                  Cr. |         48.2 |  91.7/41.7 | 28.5 |         21.1 | 0.42                  % | 15.1                  % | 11.8                  % |         2.00 | 
| Marksans Pharma Ltd |         8,634                  Cr. |         190 |  359/162 | 24.7 |         54.4 | 0.42                  % | 20.0                  % | 16.8                  % |         1.00 | 
| Mangalam Drugs and Organics Ltd |         105                  Cr. |         67.0 |  130/62.8 |  |         93.9 | 0.00                  % | 8.03                  % | 4.71                  % |         10.0 | 
| Lyka Labs Ltd |         338                  Cr. |         94.6 |  177/90.2 | 45.0 |         29.0 | 0.00                  % | 9.91                  % | 9.31                  % |         10.0 | 
| Lupin Ltd |         90,578                  Cr. |         1,984 |  2,403/1,774 | 24.5 |         377 | 0.60                  % | 21.3                  % | 20.6                  % |         2.00 | 
| Lincoln Pharmaceuticals Ltd |         1,066                  Cr. |         533 |  980/499 | 12.4 |         335 | 0.34                  % | 17.3                  % | 12.8                  % |         10.0 | 
| Laurus Labs Ltd |         52,608                  Cr. |         975 |  980/474 | 77.0 |         91.1 | 0.12                  % | 9.47                  % | 7.75                  % |         2.00 | 
| Kwality Pharmaceuticals Ltd |         916                  Cr. |         883 |  1,235/596 | 21.1 |         256 | 0.00                  % | 18.2                  % | 16.2                  % |         10.0 | 
| Krebs Biochemicals & Industries Ltd |         149                  Cr. |         69.4 |  129/63.6 |  |         67.8 | 0.00                  % | 30.1                  % | % |         10.0 | 
| Kopran Ltd |         800                  Cr. |         166 |  327/154 | 22.9 |         107 | 1.81                  % | 9.75                  % | 7.64                  % |         10.0 | 
| Kilitch Drugs (India) Ltd |         657                  Cr. |         378 |  500/265 | 23.5 |         116 | 0.00                  % | 15.7                  % | 12.6                  % |         10.0 | 
| Jubilant Pharmova Ltd |         18,693                  Cr. |         1,170 |  1,310/802 | 37.6 |         414 | 0.43                  % | 9.54                  % | 9.55                  % |         1.00 | 
| J B Chemicals & Pharmaceuticals Ltd |         26,848                  Cr. |         1,712 |  1,955/1,303 | 39.2 |         221 | 0.91                  % | 25.8                  % | 20.1                  % |         1.00 | 
| Jagsonpal Pharmaceuticals Ltd |         1,512                  Cr. |         226 |  328/193 | 35.5 |         36.1 | 1.10                  % | 23.0                  % | 18.6                  % |         2.00 | 
| Ipca Laboratories Ltd |         33,202                  Cr. |         1,310 |  1,758/1,168 | 37.1 |         274 | 0.31                  % | 14.7                  % | 12.8                  % |         1.00 | 
| IOL Chemicals & Pharmaceuticals Ltd |         2,771                  Cr. |         94.5 |  127/57.5 | 26.3 |         57.5 | 0.85                  % | 8.86                  % | 6.13                  % |         2.00 | 
| Ind-Swift Ltd |         85.4                  Cr. |         15.8 |  34.7/12.0 | 10.9 |         74.2 | 0.00                  % | 11.9                  % | % |         2.00 | 
| Ind-Swift Laboratories Ltd |         751                  Cr. |         102 |  124/67.2 | 34.1 |         194 | 0.00                  % | 0.78                  % | 0.18                  % |         10.0 | 
| Indoco Remedies Ltd |         2,547                  Cr. |         275 |  355/190 |  |         111 | 0.07                  % | 0.49                  % | 7.02                  % |         2.00 | 
| Hikal Ltd |         3,002                  Cr. |         244 |  465/236 | 47.4 |         102 | 0.57                  % | 9.85                  % | 7.38                  % |         2.00 | 
| Hester Biosciences Ltd |         1,388                  Cr. |         1,630 |  2,786/1,243 | 36.9 |         369 | 0.43                  % | 9.71                  % | 9.18                  % |         10.0 | 
| Gufic BioSciences Ltd |         3,297                  Cr. |         328 |  504/285 | 53.9 |         60.0 | 0.03                  % | 13.2                  % | 12.3                  % |         1.00 | 
| Granules India Ltd |         13,928                  Cr. |         574 |  628/412 | 29.2 |         153 | 0.26                  % | 15.1                  % | 13.9                  % |         1.00 | 
| Glenmark Pharmaceuticals Ltd |         53,597                  Cr. |         1,898 |  2,286/1,275 | 40.2 |         314 | 0.13                  % | 19.4                  % | 15.8                  % |         1.00 | 
| Glaxosmithkline Pharmaceuticals Ltd |         45,350                  Cr. |         2,683 |  3,516/1,921 | 47.9 |         115 | 1.57                  % | 63.2                  % | 46.9                  % |         10.0 | 
| Gland Pharma Ltd |         32,480                  Cr. |         1,972 |  2,131/1,200 | 28.1 |         610 | 0.91                  % | 15.8                  % | 11.6                  % |         1.00 | 
| FDC Ltd |         7,491                  Cr. |         460 |  559/359 | 27.8 |         140 | 1.09                  % | 15.9                  % | 11.8                  % |         1.00 | 
| ERIS Lifesciences Ltd |         21,795                  Cr. |         1,597 |  1,910/1,097 | 56.3 |         210 | 0.46                  % | 12.2                  % | 12.9                  % |         1.00 | 
| Dr Reddys Laboratories Ltd |         99,807                  Cr. |         1,196 |  1,406/1,020 | 17.3 |         432 | 0.67                  % | 22.7                  % | 18.0                  % |         1.00 | 
| Dishman Carbogen Amcis Ltd |         4,582                  Cr. |         292 |  322/177 | 38.6 |         372 | 0.00                  % | 2.42                  % | 0.32                  % |         2.00 | 
| Cipla Ltd |         1,22,066                  Cr. |         1,512 |  1,673/1,310 | 22.4 |         408 | 0.86                  % | 22.7                  % | 17.8                  % |         2.00 | 
| Caplin Point Laboratories Ltd |         15,247                  Cr. |         2,006 |  2,641/1,551 | 27.0 |         347 | 0.30                  % | 25.8                  % | 22.7                  % |         2.00 | 
| Brooks Laboratories Ltd |         329                  Cr. |         112 |  203/95.6 | 162 |         33.3 | 0.00                  % | 9.93                  % | 12.2                  % |         10.0 | 
| Bliss GVS Pharma Ltd |         1,643                  Cr. |         155 |  191/105 | 15.4 |         99.7 | 0.32                  % | 11.7                  % | 8.36                  % |         1.00 | 
| Biofil Chemicals & Pharmaceuticals Ltd |         65.2                  Cr. |         39.8 |  72.1/38.0 | 23.4 |         11.5 | 0.00                  % | 4.12                  % | 3.03                  % |         10.0 | 
| Biocon Ltd |         50,437                  Cr. |         377 |  406/291 | 139 |         180 | 0.13                  % | 6.25                  % | 4.76                  % |         5.00 | 
| Beta Drugs Ltd |         1,834                  Cr. |         1,817 |  2,215/1,430 | 40.0 |         195 | 0.00                  % | 27.0                  % | 25.9                  % |         10.0 | 
| Bal Pharma Ltd |         132                  Cr. |         82.5 |  141/76.3 | 18.4 |         48.6 | 1.45                  % | 10.1                  % | 9.66                  % |         10.0 | 
| Bafna Pharmaceuticals Ltd |         332                  Cr. |         151 |  179/67.8 | 32.9 |         35.8 | 0.00                  % | 8.34                  % | 7.69                  % |         10.0 | 
| Astrazeneca Pharma India Ltd |         24,619                  Cr. |         9,828 |  10,691/6,220 | 116 |         308 | 0.33                  % | 33.4                  % | 23.6                  % |         2.00 | 
| Amrutanjan Health Care Ltd |         2,072                  Cr. |         717 |  843/544 | 38.0 |         113 | 0.64                  % | 22.4                  % | 16.5                  % |         1.00 | 
| Alpa Laboratories Ltd |         190                  Cr. |         90.3 |  137/85.0 | 7.23 |         86.4 | 0.00                  % | 15.0                  % | 11.5                  % |         10.0 | 
| Alkem Laboratories Ltd |         67,291                  Cr. |         5,628 |  5,961/4,492 | 29.6 |         1,002 | 0.80                  % | 20.4                  % | 19.4                  % |         2.00 | 
| Alembic Pharmaceuticals Ltd |         18,182                  Cr. |         924 |  1,153/725 | 30.7 |         264 | 1.19                  % | 13.0                  % | 11.4                  % |         2.00 | 
| Albert David Ltd |         504                  Cr. |         883 |  1,540/763 | 80.1 |         688 | 0.57                  % | 6.45                  % | 4.39                  % |         10.0 | 
| Ajanta Pharma Ltd |         31,741                  Cr. |         2,539 |  3,148/2,022 | 32.6 |         345 | 1.10                  % | 32.4                  % | 24.9                  % |         2.00 | 
| Advanced Enzyme Technologies Ltd |         3,572                  Cr. |         319 |  509/258 | 26.1 |         127 | 1.63                  % | 13.1                  % | 9.54                  % |         2.00 | 
| Aarti Drugs Limited |         4,633                  Cr. |         503 |  575/312 | 25.9 |         136 | 0.20                  % | 13.5                  % | 13.0                  % |         10.0 | 
| Industry Average | 19,966.35 Cr | 1,197.73 |  | 54.46 | 195.30 | 0.33% | 16.24% | 14.95% | 6.10 |